A PROSPECTIVE STUDY ON RELATION OF HISTOLOGICAL GRADE AS WELLAS HORMONE RECEPTOR PROFILE IN LOCALLY ADVANCED BREAST CARCINOMA PATIENTS IN RESPONSE TO NEOADJUVANT CHEMOTHERAPY-Reference-Cited by-同舟云学术

A PROSPECTIVE STUDY ON RELATION OF HISTOLOGICAL GRADE AS WELLAS HORMONE RECEPTOR PROFILE IN LOCALLY ADVANCED BREAST CARCINOMA PATIENTS IN RESPONSE TO NEOADJUVANT CHEMOTHERAPY

Published:2021-03-01 Issue: Volume: Page:59-61
ISSN:
Container-title:INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH
language:en
Short-container-title:ijsr

Author:

Ranjan Samir¹,Gupta Arun²

Affiliation:

1. Assistant Professor, Department Of General Surgery, R.g. Kar Medical College & Hospital

2. Department Of General Surgery, R.g. Kar Medical College & Hospital

Abstract

Introduction: Inltrating ductal carcinoma being the most common type of carcinoma (70%), lobular carcinoma is the 2nd most common followed by smaller groups such as medullary, mucinous,comedo, paget's disease, papillary, tubular and inammatory carcinoma. Aims and objectives:To establish incidence and correlation between ER, PR, HER 2 neu receptor status, histology with different patient proles. Assessment of therapeutic effectivity and its relation with receptor status and histology after neoadjuvant chemotherapy. Material and methods: This will be an institution-based observational and prospective study. Lab studies- hemoglobin, total count, fasting and postprandial blood sugar, urea, creatinine, albumin and total protein Pretested and predesigned perform Conclusion: This study shows that age group is an important factor for developing breast carcinoma, which was more prevalent in premenstrual population.

Publisher

World Wide Journals

Reference11 articles.

1. Mamounas EP. NSABP breast cancer clinical trials: recent results and future directions. Clin Med Res 2003; 4: 309-326.

2. Rastogi P, Anderson SJ, Bear HD, Geyer CE, Kahlenberg MS, Robidoux A, Margolese RG, Hoehn JL, Vogel VG, Dakhil SR, Tamkus D, King KM, Pajon ER, Wright MJ, Robert J, Paik S, Mamounas EP, Wolmark N. Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27. J ClinOncol 2008; 26: 778- 785.

3. Tabassoli FA, Devilee P. World Health Organization classification of tumours. Pathology and genetics, Tumours of the breast and female genital organs. Lyon: IARC Press; 2003. 13e14.

4. Harris L, Fritsche H, Mennel R, Norton L, Ravdin P, Taube S, et al. American society of clinical oncology 2007 update of recommendations for the use of tumor markers in breast cancer. J ClinOncol2007;25:5287e531.

5. Fehm T, Becker S, Becker-Pergola G, Sotlar K, Gebauer G, DurrStorzer S, et al. Presence of apoptotic and nonapoptotic disseminated tumor cells reflects the response to neoadjuvant systemic therapy in breast cancer. Breast Cancer Res 2006;8:R60.